Introduction Protein labelling using bioorthogonal ligation chemistry
Site-specific labelling of proteins with chemical or fluorescent 15 probes is a prerequisite for many established and emerging techniques in chemical and cell biology.
1-3 Protein labelling technology has been revolutionised by the discovery of highly selective, water-compatible reactions that permit bioorthogonal ligation of a synthetic probe at a defined site 20 that bears a small chemical tag such as an azide, alkyne or aldehyde. 4 Bioorthogonal ligation chemistry has proven to be robust, 5 and has been used in a remarkable range of applications for labelling proteins and other biomolecules both in vitro and in vivo. 6 However, there remains a need for 25 methods that allow the introduction of suitable tags into a protein in both an efficient and site-specific manner, particularly in live cells. Two distinct approaches have been developed to address this problem, which enable introduction of tagged sites at 30 either the DNA or protein level. Expanded codon usage, first pioneered by the Schultz group, enables incorporation of a tagged amino acid at an arbitrary number of specific sites encoded in the parent gene. 7, 8 Alternatively, the protein can be modified post-translationally to introduce a chemical 35 modification bearing a bioorthogonal tag at a suitable consensus motif. A growing range of enzymes have been adapted for use in this approach, including farnesyl transferases, 9,10 biotin ligase 11 and formylglycine-generating enzyme. 12 Despite the great potential of these techniques, 40 their adoption for general labelling applications can be limited by the need for relatively complex synthetic and biochemical protocols.
We recently communicated 13 a straightforward and practical transferase-based technique that permits site-specific 45 in vitro and in vivo generation of N-terminal azide-tagged recombinant protein, and subsequent labelling with Staudinger-Bertozzi ligation chemistry. 14 Here we report this work in full, and extend the scope to encompass transferasemediated in vivo production of alkynyl-tagged proteins and 50 subsequent bioorthogonal labelling with [3 + 2] azide-alkyne cycloaddition ('click' chemistry). 4 
Myristoyl-CoA:protein N-myristoyl transferase (NMT)
N-Myristoylation at an N-terminal glycine is a constitutive co-translational modification that occurs in all eukaryotic 55 cells, and contributes to regulation of signalling and trafficking by modulating protein-membrane and proteinprotein associations. 15 Myristoyl-CoA:protein N-myristoyl transferase (NMT), the enzyme that catalyses myristoylation, has been characterised in a wide range of organisms, from 60 yeast to humans. [16] [17] [18] [19] [20] [21] Comprehensive studies by Gordon et al. found that the specificity of Saccharomyces cerevisiae NMT (ScNMT) towards fatty acyl-coenzyme A (CoA) analogues is limited to acids that closely mimic myristoyl-CoA (2, Fig. 1 ), particularly with respect to chain length (~14 heteroatoms) 65 and flexibility. [22] [23] [24] Nevertheless, this early work suggested that ScNMT tolerates the introduction of some functionality in the acyl chain of the myristoyl-CoA substrate and recent reports have also described the use of modified myristate for non-radioactive metabolic labelling in mammalian cell 70 lines. 25, 26 Encouraged by this work, we decided to investigate transfer of alkyne-and azide-modified myristate analogues by NMT as a means for introducing a bioorthogonal ligation tag at the N-terminus of proteins bearing an N-terminal myristoylation motif. 
Results and Discussion

Design and synthesis of tagged substrates for NMT
A well-characterised and widely-used NMT cloned from Candida albicans (CaNMT) 18 was selected as the azido-or alkynyl-myristate transfer agent. This enzyme exhibits 5 excellent stability, activity and solubility, and may be overexpressed and purified without the need for an affinity tag. 27 Two myristic acid analogues were designed, incorporating an azide (3) or alkyne (4) at the terminal position (Fig. 1 ) so as to mimic the chain length and flexibility of the natural substrate 10 as closely as possible. In 11-azido undecanoic acid 3, three carbon atoms were replaced by the three nitrogen atoms of the azide, whilst in tetradec-13-ynoic acid 4, the terminal single bond was replaced by a triple bond. It was hypothesised that these relatively minor modifications would not have a 15 significant impact on the affinity of the acyl-CoA substrate for CaNMT. 18, 27 The long alkyl chain in 3 and 4 would also be expected to act as a flexible linker between protein and tag, potentially serving to improve the accessibility of the tag for subsequent modification.
20
3 And 4 were synthesised in one or two steps starting from commercially-available ω-bromo acids (Scheme 1). Simply reacting 11-bromo undecanoic acid with sodium azide in DMSO furnished 3 in excellent yield, whilst a sequence of bromine displacement from 12-bromo dodecanoic acid with 25 lithium trimethylsilyl acetylide followed by base-mediated deprotection gave 4 in good overall yield. Each analogue was then converted to the corresponding acyl-CoA thioester by activation with 1,1'-carbonyldiimidazole (CDI) and reaction with CoASH (trisodium salt) under basic conditions. Scheme 1 Synthesis of myristic acid analogues 3 and 4, and their corresponding CoA thioester analogues 5 and 6. Reagents and conditions: i) NaN3, DMSO; ii) a) CDI, THF, b) CoASH, THF-NaHCO3 (0.5 M); iii) TMS-Acetylene, n BuLi, THF-HMPA, -78 °C; iv) K2CO3, MeOH.
35
In vitro azido-and alkynyl-tagging of a peptide substrate
A series of initial experiments were performed to demonstrate that 5 and 6 are indeed substrates for CaNMT. A model peptide substrate H-GLYVSRLFNRLFQKK-NH 2 (7) bearing a canonical N-terminal myristoylation motif of general 40 sequence GXXXS (X = any amino acid) 28-30 was synthesised by standard Fmoc/tBu solid phase peptide synthesis (SPPS). 7 Corresponds to the N-terminal region of Plasmodium falciparum ADP ribosylation factor 1 (PfARF1), 16 ,31-33 which we have shown previously to be a substrate for CaNMT. The 45 corresponding N-terminal azido-myristoylated (8) and alkynyl-myristoylated (9) analogues of 7 were synthesised by capping the resin with 3 or 4 respectively prior to cleavage.
Incubation of equimolar quantities of 7 and one of the two acyl-CoA substrates (5 or 6) in the presence of a catalytic 50 quantity of CaNMT (0.25 mol %) in a suitable buffer for up to 2 hours was sufficient for complete transfer of the acyl group to the target peptide as determined by HPLC (Fig. 2) . In each case 7 was rapidly consumed during the reaction. Interestingly, transfer from the alkyne-tagged myristoyl-CoA 55 analogue 6 appears to be at least two-fold faster than from the azide-tagged substrate 5, which may reflect a higher affinity for the selective myristoyl-CoA binding pocket. Both analogues are transferred at a rate comparable to that of the native substrate 2. 
In vivo azido-and alkynyl-tagging of a recombinant protein
Having confirmed that CaNMT will transfer the tagged acyl group from acyl-CoA substrates 5 and 6 in vitro, we next sought to apply this technique for tagging and subsequent 70 labelling of a recombinant protein.
† Previous work has shown that E. coli engineered to co-express NMT and a substrate protein provides a practical system to study myristoylation in vivo in isolation from other cellular processes. 34, 35 Whilst bacteria are competent to convert myristic acid to the 75 activated CoA thioester via acyl-CoA synthetase 36 they do not possess protein N-myristoyl transferases, which are an enzyme class exclusive to eukaryotes. Furthermore, in common with eukaryotes, bacteria express methionine aminopeptidase (MetAP), 37 which is required to strip the leader methionine 80 from a substrate protein to reveal the requisite N-terminal glycine. These properties make the bacterial co-expression system a useful tool for the production of N-myristoylated proteins.
E. coli
Cell Membrane In the co-expression approach bacteria are transformed with a pair of expression constructs containing the NMT and substrate sequences together with orthogonal antibiotic 10 resistance genes; under double antibiotic selection the bacteria retain both plasmids. Simultaneous feeding with myristic acid and induction in the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG) causes the bacteria to express both proteins, and myristic acid is transferred to the substrate 15 inside the bacteria. We hypothesised that acids 3 and 4 could be used directly in such a co-expression system to enable the generation of tagged protein, as outlined in Fig. 3 . The success of this approach would depend on both sufficient uptake of the myristic acid analogues and their acceptance as 20 substrates by bacterial acyl-CoA synthetase. This methodology would offer two key advantages over the in vitro approach:
• It removes the requirement for synthesis of the acyl-CoA thioester, thus limiting the reagents required to cheap and 25 readily available compounds.
• Expression and isolation of the target tagged protein can be achieved in a single experiment, without the need for separate purification and isolation of either NMT or substrate.
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A set of capture reagents were designed and synthesised to enable the detection of protein tagging via bioorthogonal ligation of a biotin label to either azide-or alkyne-tagged targets (Scheme 2). The syntheses described here are significantly simplified from those reported in previous 35 studies, and can be carried out in as few as three steps, starting from commercially-available Biotin-PEG NovaTag™ resin. In each case, an acid bearing the appropriate capture group (pent-4-ynoic acid 10, 4-azidobutyric acid 11 or 3-(diphenylphosphino)-4-(methoxycarbonyl) benzoic acid 12) 40 was preactivated with HATU and coupled in 4-fold excess relative to resin loading. Subsequent cleavage (95% aqueous TFA) and purification by RP-HPLC afforded the corresponding capture reagents bearing an azide (13), alkyne (14) or triarylphosphine (15) moiety in good overall yield. conjugate. A known endogenous biotinylated E. coli protein of ca. 22 kDa is observed in all samples in B and C (marked by *). 38 As shown in Fig. 4 , transfer of both azido-and alkynylacids are observed only in the presence of CaNMT, and subsequent capture is highly specific for the tagged substrate. 20 No significant capture of either myristoylated PfARF1 or endogenous E. coli proteins is observed under the conditions used. Furthermore, no labelling is observed in cells overexpressing CaNMT with a PfARF1[G2A] mutant protein bearing an alanine at the N-terminus ( Fig. 4B and C, lanes 2 25 and 4), demonstrating that the present method is highly sitespecific for an N-terminal Gly residue. The band observed below PfARF1 (Fig. 4B and C, lanes 1-9) 39 This is likely due to the enhancement in rate in the presence of a large excess of activated alkyne in the case of capture using reagent 14; in the 40 case of capture with 13, the rate is presumably limited by the relatively lower concentration of activated alkynyl-protein.
Conclusions
In summary, we have reported a novel method for in vivo co-translational site-specific introduction of an azide or 45 alkyne chemical tag during expression of a recombinant protein. Subsequent elaboration via click chemistry has been used to introduce a biotin label for visualisation by gel electrophoresis, and in principle it should be possible to adapt this approach for the introduction of a wide range of labels.
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The canonical N-myristoylation motif GXXXS has been shown to direct N-terminal tagging to a single specific site. In addition to providing a convenient and potentially general method for N-terminal recombinant protein labelling, this system also provides a useful model system and proof-of-55 principle for in vivo 'tagging-by-substrate' studies aimed at elucidating the myristoylated proteome (or 'myristome') in cells in culture or in multicellular organisms. 25, 26 Post-and cotranslational methods for protein labelling also present the potential for orthogonal multi-site protein labelling in 60 combination with other enzymatic techniques. We envisage that the system presented here could be combined with related approaches reported for the post-translational introduction of tags, 9,10,12 to enable site-specific labelling of a protein with a FRET pair, for example. Work is ongoing in our labs to 65 extend the methodology presented here for the labelling of other recombinant proteins for biophysical and bioconjugate studies.
Experimental
Materials and Methods
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All solvents were purchased from BDH and used without further purification. All reagents, unless otherwise stated, were purchased at the highest quality available from SigmaAldrich and used without further purification. NMR spectra were recorded in 5 mm tubes calibrated to the residual solvent 75 peak stated, on Bruker AV-400 and AV-500 spectrometers. COSY and HMQC correlation spectra were used to aid assignment where necessary. Samples were characterised by MALDI-TOF (positive reflectron mode) mass spectrometry, recorded on a Micromass Autospec-Q spectrometer. hexanes (4.30 mL, 2.5 M, 10.74 mmol). The reaction mixture was allowed to warm up to room temperature for a few seconds before cooling to -78 °C. To this mixture was added a solution of 12-bromododecanoic acid (1.00 g, 3.58 mmol) in dry THF (20 mL) and dry HMPA (13 mL) dropwise. The 30 reaction was allowed to warm to room temperature and stir until complete. Upon completion (after 18 hours, followed by TLC) the reaction mixture was returned to -78 °C and quenched by the addition of saturated NH 4 Cl (aq.) . The aqueous layer was extracted with DCM (3 × 50 mL) and the combined 35 organic layers were washed with brine (3 × 50 mL) before drying over MgSO 4 and concentration under reduced pressure. The product was purified by flash column chromatography (nhexane-ethylacetate (1:1), R f = 0.48). The TMS protected alkyne was taken up in MeOH (10 mL) and to this was added 40 K 2 CO 3 (192.2 mg). The reaction mixture was stirred at room temperature for 18 hours, after which time all volatiles were removed under reduced pressure and the residues partitioned between ethylacetate-HCl (aq.) (1:1, 60 mL). The aqueous phase was extracted with ethylacetate (3 × 30 mL) and the 45 combined organic phases dried and concentrated as before. The product was isolated as clear colourless oil and required no further purification (199.3 mg, 25% Retention time = 23.3 min, detection was at 258 nm. The product was isolated as a white amorphous solid (11. 4 and backbone elongation (coupling) mediated by HBTU and DIPEA (N,N'-diisopropylethylamine) (45 min). The coupling reaction used a 5-fold excess of amino acid to resin, 1 equivalent of HBTU and 2 eq. DIPEA. The coupling stage was repeated twice for the attachment of the first amino acid 25 to the resin. After elongation and final Fmoc deprotection, the resin was washed with 1 × 1 mL DMF, 3 × 1 mL DCM and 3 × 1 mL MeOH before being allowed to dry in a desiccator overnight. Manual deprotection was accomplished by the addition of 1 mL of 95% TFA, 2.5% H 2 O and 2.5% 30 triisopropyl silane (TIS) with thorough mixing by vortex. The supernatant was displaced through the frit into a 12 mL centrifuge tube and the beads washed in a similar manner with a further 0.5 mL TFA. The combined washings were treated with ~9.5 mL TBME (cooled to -20 °C) to precipitate the 35 peptides. The solids were pelleted by centrifugation for 15 min at 4300 rpm at 4 °C and washed (with vortexing and centrifugation) repeatedly in TBME (three times in total). The pelleted solids were dried in a desiccator overnight. The deprotected peptides were purified by semi-preparative N-(15-Oxo-19-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecyl) 
Protein expression and in vivo tagging
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Recombinant CaNMT and PfARF1: CaNMT was cloned into pET11c (ampicillin resistance), expressed in E. coli and purified as described. 27 PfARF1 wild-type and G2A mutant proteins were cloned into pET28a (kanamycin resistance), expressed in E. coli and purified as reported previously. 
Gel-based analysis
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SDS PAGE: Proteins were separated by SDS-PAGE using 1 mm Bis-Tris gels (4% stacking gel, 12% resolving gel) in NuPAGE ® MES SDS running buffer (Invitrogen). Samples were prepared by boiling for 5 minutes in NuPAGE ® LDS sample loading buffer (4 × Biosciences) using a semi-dry electrophoretic transfer method. The membranes were blocked for 1 hour in BSA (5% in buffer C) before washing for 3 × 10 min in buffer C. The blots were probed using the appropriate antibody-HRP conjugate (anti-5 × His or NeutrAvidin TM ) at 1:5000 dilution in buffer C for 100 1 hour at room temperature. The membranes were then washed with buffer C for 3 × 5 min before detection using the enhanced chemiluminescence (ECL) kit according to the manufacturer's instructions (Amersham Biosciences). London, SW7 2AZ, UK. † We have previously shown that a recombinant protein can be tagged in vitro using CaNMT. In this instance tagging of protein proceeds in a similar manner to tagging of the peptide substrates described above. 13 ‡ Note that in our previous work 13 we deliberately depleted the lysate of 10 this biotinylated protein prior to capture; this step may be omitted for convenience as in the present report. 
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